Use of MBDS as a tool for the detection of drug-related adverse events;Utilización del CMBD como herramienta para la detección de acontecimientos adversos a medicamentos

Farmacia Hospitalaria

Volumn 28, Issue 4, 2004, Pages 258-265

  Corral Baena, Susana ^a   Guerrero Aznar, M D ^a   Beltran Garcia M ^a   Salas Turrens, J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Avoidability; Drug related adverse events; Drug related adverse reactions; Medication errors

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; CORTICOSTEROID; DIGOXIN; DIURETIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL ANTIDIABETIC AGENT;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; AVOIDABILITY; DATA BASE; DISEASE SEVERITY; DRUG RELATED ADVERSE EVENT; EMERGENCY WARD; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PHARMACY; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MINIMUM BASIC DATA SET; SAFETY;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DRUG THERAPY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICAL RECORDS; MEDICATION ERRORS; MIDDLE AGED; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; SAFETY MANAGEMENT;

EID: 4644324844     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Muñoz MJ, Ayani I, Rodríguez Sasiain JM, Gutiérrez G, Aguirre C. Monitorización en un Servicio de Urgencias de reacciones adversas causadas por medicamentos en niños y adultos. Med Clin (Barc) 1998; 111: 92-8.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drugs reactions in hospitalized patients. A meta-analisys of prospective studies. JAMA 1998; 279: 1200-5.
3. Joyanes A, Higueras LM, De León J, Sanz E. Análisis de las reacciones adversas detectadas en un centro de atención primaria. Aten Primaria 1996; 17 (4): 262-7.
4. Bates DW, Leape LL, Petrycki S. Incidence of adverse drug events in hospitalized adults. J Gen Intern Med 1993; 8: 289-94.
5. Leape LL, Kabcenell A, Berwick DM, Roessner J. Breakthrough Series Guide: reducing adverse drug events. Boston: Institute for Healthcare Improvement, 1998.
6. Requirements for adverse reaction reporting. Geneva, Switzerland: World Health Organization, 1975.
7. The United States Pharmacopeial Convention. National Council focuses on coordinating error reduction efforts. Quality Review (newsletter) 1997; 57: 1-4.
8. a ed. Madrid: SCM, 2002. p. 586-9.
9. Torelló J. Papel del CMBDH en Farmacovigilancia. Ventajas y limitaciones de una herramienta infrautilizada. Arch Fac Med Zaragoza 2001; 41 (Supl. 1): 24-8.
10. WHO. Collaborating Centre for International Drug Monitoring. International monitoring of adverse drug reactions. Ginebra, 1988.
11. Consejo General de Colegios Oficiales de Farmacéuticos. Catálogos de especialidades Farmacéuticas. Madrid, 1995.
12. Otero López MJ, Bajo Bajo A, Maderuelo Fernández JA, Domínguez-Gil Hurlé A. Evitabilidad de los acontecimientos adversos inducidos por medicamentos detectados en un Servicio de Urgencias. Rev Clin Esp 1999; 199: 796-805.
13. th ed). Oxford: Oxford University Press, 1991. p. 18-45.
14. Anónimo. Centros Autónomos de Farmacovigilancia: Ministerio de Sanidad y Consumo, 1994.
15. Pollock B. Psichotropic drugs and the aging patient. Geriatrics 1998; 53 (Supl. 1): S20-4.
16. Simmons C, Georgeson M, Hill RC. Adverse drug reactions. Can we reduce the risk? Hosp Pharm 1998; 33: 1568-76.
17. Evans RS, Classen DC, Horn SD, et al. Preventing adverse drug events in hospitalized patients. Ann Pharmacoter 1994; 28: 523-7.
18. Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery PR. Drug-associated hospital admissions in older medical patients. J Am Genalt Soc 1988; 36: 1092-8.
19. Courtman BJ, Stallings SB. Characterizacion of drug-related problems in elderly patients on admission to a medical ward. Can J Hosp Pharm 1995; 48: 161-6.
20. Col N, Fanale JF, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841-5.
21. Prosser T, Kamysz P. Multidisciplinary adverse drug reaction surveillance program. Am J Hosp Pharm 1990; 47: 1334-9.
22. O'Neil AC, Petersen LA, Cook EF, et al. Physician reporting compared with medical-record review to identify adverse medical events. Am Intern Med 1993; 119: 370-6.
23. Bates DW, O'Neil AC, Boyle D, et al. Potential identifiability and preventability of adverse drug events using information systems. J Am Med Informatics Assos 1994; 1: 404-11.
24. Grasela T, Walaander CA, Kennedy DL, et al. Capability of hospital computer systems in performing drug-use evaluations and adverse drug event monitoring. Am J Hosp Pharm 1993; 50: 1889-95.
25. ASHP national survey of pharmacy practise in acute care settings: Prescribing and transcribing-1998. Am J Health-Syst Pharm 1999; 56: 142-57.
26. Otero MJ, Domínguez-Gil A. Acontecimientos adversos por medicamentos: una patología emergente. Farm Hosp 2000; 24 (4): 258-66.
27. Otero MJ, Bajo A, García Gutiérrez JF, Domínguez-Gil A. ¿Prevenible o inevitable?: una nueva etapa en el tema de la seguridad de los medicamentos. Med Clin (Barc) 1999; 112: 398-9.
28. Leape LL, Bates DW, Cullen DJ, et al. Systems analisys of adverse drug events. JAMA 1995; 274: 35-43.
29. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patientes. Results of the Harvard Medical Practice Study 11. N England J Med 1991; 324: 377-84.
30. Pearson TF, Pittman DG, Longley JM, Grapes T, Vigliotti DJ, Mullis SR. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994; 51: 2268-72.
31. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997; 277: 312-7.